Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtrer
1.
Article de Anglais | WPRIM | ID: wpr-109990

RÉSUMÉ

Escitalopram is a selective serotonin reuptake inhibitor antidepressant approved by the Food and Drug Administration for the treatment of major depressive disorder and generalized anxiety disorder. A 34-year-old female patient with major depressive disorder developed amenorrhea and had a false-positive urine pregnancy test after initiation of escitalopram treatment. To our knowledge, no published case report of amenorrhea and false-positive urine pregnancy tests in women taking escitalopram exists. This case report suggests that women of child-bearing age should be carefully monitored for amenorrhea while they are on an antidepressant treatment regimen.


Sujet(s)
Adulte , Femelle , Humains , Grossesse , Grossesse , Aménorrhée , Troubles anxieux , Citalopram , Trouble dépressif majeur , Hyperprolactinémie , Tests de grossesse , Tests immunologiques de grossesse , Sérotonine , Inbiteurs sélectifs de la recapture de la sérotonine , Food and Drug Administration (USA)
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE